Skip to main content
. 2022 Nov 17;14(22):5640. doi: 10.3390/cancers14225640

Table 2.

Characteristics of thrombotic events occurred within 45 days from acute myeloid leukemia diagnosis.

Age Sex Type of TE Onset from AML Diagnosis (Days) History of VTE n° of Comorbidities TE Pre/Post AML-Therapy
1 66 M hepatic veins thrombosis 1 no 2 pre
2 47 F CRT 8 no 2 pre
3 63 M CRT 10 no 1 post
4 68 M DVT+PE 1 no 3 pre
5 53 M MI 1 no 2 pre
6 44 F CRT 11 no 1 post
7 71 F PE 12 no 2 post
8 63 M MI 35 no 2 post
9 81 M CRT 18 no 2 pre
10 70 M DVT 1 no 2 pre
11 68 M CRT 4 no 2 pre
12 49 F CRT 11 no 2 post
13 64 F CRT 10 no 1 pre
14 30 M CRT 8 no 0 pre
15 58 M CRT 5 no 2 pre
16 63 F DVT 1 yes 1 pre
17 64 M DVT 3 no 3 pre
18 76 M CRT 8 no 3 post
19 61 M CRT 6 no 1 post
20 73 F PE 40 no 1 post
21 59 M CRT 36 yes 1 post
22 40 F DVT+PE 10 no 0 post
23 82 F CRT 28 no 2 pre
24 41 M CRT 34 no 0 post
25 55 M CRT 12 no 1 pre
26 64 M MI 24 no 2 post
27 75 M CRT 31 yes 1 post
28 72 M MI 13 no 1 post
29 69 F CRT 2 no 1 pre
30 73 M CRT 6 yes 1 pre
31 48 F hepatic veins thrombosis 1 no 0 pre
32 72 M CRT 3 no 1 pre
33 55 M CRT 10 no 3 pre
34 68 M MI 24 no 2 pre
35 67 F CRT 10 yes 3 pre
36 77 M MI 25 no 4 post

TE, thrombotic event; AML, acute myeloid leukemia; VTE, venous thrombotic event; M, male; F, female; CRT, catheter-related thrombosis; MI, myocardial infarction; DVT deep-venous thrombosis; PE, pulmonary embolism.